Understand the source comparison
Melatonin vs Pinealon: Comparison Table
Molecular Class Indoleamine neurohormone Tripeptide bioregulator Melatonin is a hormone; Pinealon is a peptide. Fundamentally different molecule types Mechanism of Action Binds MT1/MT2 receptors in suprachiasmatic nucleus to phase-shift circadian clock Modulat
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Molecular Class
- Indoleamine neurohormone
- Tripeptide bioregulator
- Melatonin is a hormone; Pinealon is a peptide. Fundamentally different molecule types
- Mechanism of Action
- Binds MT1/MT2 receptors in suprachiasmatic nucleus to phase-shift circadian clock
- Modulates gene expression in pinealocytes through chromatin interaction. Does not bind melatonin receptors
- Melatonin = receptor-mediated signaling; Pinealon = epigenetic regulation
- Onset of Effect
- 20–60 minutes (plasma peak 60–150 min oral)
- Genomic changes detectable at 24–72 hours; functional outcomes require weeks
- Melatonin is fast-acting; Pinealon is slow-acting with cumulative effects
- Half-Life
- 20–50 minutes (hepatic CYP1A2 metabolism)
- 30–45 minutes (rodent subcutaneous data)
- Both are short half-life compounds requiring repeated dosing
- Evidence Base
- 3,000+ trials, multiple Cochrane reviews, FDA-recognized GRAS status as supplement
- ~20 published studies, primarily Russian gerontology research, no Phase III RCTs
- Melatonin has extensive clinical validation; Pinealon has preclinical promise with limited human data
- Primary Use Case
- Circadian rhythm disorders, jet lag, shift work, sleep onset insomnia
- Aging research, neuroprotection models, pineal gland function studies
- Choose melatonin for immediate circadian manipulation; Pinealon for long-term cellular aging research